LCTX
Lineage Cell Therapeutics, Inc.
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Lineage Cell Therapeutics (LCTX) Stock: Buy, Sell, or Hold?
$0.82
-0.02 (-2.21%)
▼
5d:
-17.2%
30d:
-13.82%
90d:
-24.07%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 12, 2026
Updated Nov 19, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
57/100
Position
OVERSOLD
30-Day Fair Range
$0.90 – $1.05
Position: OVERSOLD
Forward P/E & Valuation
-7.5x
Next 12M consensus est.
Wall Street Target
$5.50
+570.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.77 / $1.13
Trend: Correction / Pullback
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LCTX is down 17.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When LCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LCTX is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $0.90 to $1.05.
Technical Outlook: Technically, LCTX is showing correction / pullback momentum. Immediate support is located at $0.77, while resistance sits at $1.13.
Market Sentiment: LCTX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+570.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LCTX is showing correction / pullback momentum. Immediate support is located at $0.77, while resistance sits at $1.13.
Market Sentiment: LCTX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+570.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.90 -
$1.05
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.90 -
$1.05
Current vs Trading Range
OVERSOLD
Support Level
$0.77
Resistance Level
$1.13
Current Trend
Correction / Pullback
Technical data as of
Nov 18, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
6d (66% conf)
30D Insider Cluster Signal
CLUSTER BUY
30D Insider Buyers:
3 insiders ($74,198)
30D Net Insider Flow:
+$74,198
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 570.7% below Wall St target ($5.50)
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
- WARNING: Recommendation downgraded due to -17.2% 5-day decline - wait for stabilization
Fundamental Context
Forward P/E (Next Year Est.)
-7.45
Wall Street Target
$5.50
(+570.7%)
Revenue Growth (YoY)
-61.0%
Profit Margin
16.2%
Share LCTX Analysis
Share this live LCTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LCTX)
Bullish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 18, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages express bullish sentiment towards $LCTX, drawing parallels between its current situation and that of $SLS, which saw significant price growth after positive results and FDA approval.
Key Retail Themes:
Positive results leading to price growth
FDA approval
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 19, 2026 5:06 PM ET
Data refreshes hourly during market hours. Next update: 6:06 PM
Data refreshes hourly during market hours. Next update: 6:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 41 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
24 analysts |
$1147 | 43 HOLD |
|
CLYM
Climb Bio Inc |
STRONG BUY
16 analysts |
$28 | 53 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$124 | 47 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 36 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LCTX Research Pages
LCTX Technical Chart
LCTX Price Prediction
LCTX Intrinsic Value DCF
LCTX Earnings Date
LCTX Investment Advisor
LCTX Fair Price Analyzer
LCTX Target Price Playground
LCTX 5-Day Options Simulator
LCTX LEAP Simulator
LCTX Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
LCTX Competitors
Part B: Tradestie Flagship Market Scanners